Peptide and protein transdermal drug delivery

Drug Discovery Today: Technologies

Volumn 9, Issue 2, 2012, Pages

  Herwadkar, Anushree ^a   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN G; INSULIN; INTERFERON; MONOCLONAL ANTIBODY; PARATHYROID HORMONE[1-34]; PEPTIDES AND PROTEINS; VASOPRESSIN;

ANTIGEN PRESENTING CELL; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; ELECTRIC CURRENT; ELECTROOSMOSIS; ELECTROPHORESIS; ELECTROPORATION; ELECTROREPULSION; HUMAN; IONTOPHORESIS; LASER SURGERY; MICROBUBBLE; MICRONEEDLE; MICROTECHNOLOGY; RADIOFREQUENCY ABLATION; SONOPHORESIS; TRANSDERMAL DRUG ADMINISTRATION; ULTRASOUND;

EID: 84873095634     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2011.11.007     Document Type: Review

References (49)

1. Banga, A.K. (2006) Therapeutic Peptides and Proteins: Formulation, Processing and Delivery Systems (2nd ed.), CRC Press/Taylor and Francis Group
2. Herwadkar, A. and Banga, A.K. (2011) Transdermal delivery of peptides and proteins. In Peptide and Protein Delivery (Van der Walle, C.F., ed.), pp. 69-86, Academic Press
3. Banga, A.K. (2011) Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies. CRC Press 309 pp.
4. Sivamani, R.K. et al. (2007) Microneedles and transdermal applications. Expert Opin. Drug Deliv. 4, 19-25
5. Sachdeva, V. and Banga, A.K. (2011) Microneedles and their applications. Recent Pat. Drug. Deliv. Formul. 5, 95-132
6. Banga, A.K. (2009) Microporation applications for enhancing drug delivery. Expert Opin. Drug Deliv. 6, 343-354
7. Li, G. et al. (2009) In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int. J. Pharmaceut. 368, 109-115
8. Cormier, M. et al. (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Rel. 97, 503-511
9. Daddona, P.E. et al. (2011) Parathyroid hormone (1-34)-coatedmicroneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm. Res. 28, 159-165
10. Chen, X. et al. (2009) Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J. Control. Rel. 139, 212-220
11. Martanto, W. et al. (2004) Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21, 947-952
12. Ito, Y. et al. (2006) Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29, 82-88
13. Davis, S.P. et al. (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans. Biomed. Eng. 52, 909-915
14. Chen, H. et al. (2009) Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J. Control. Rel. 139, 63-72
15. Banga, A.K. (2007) Theme section: transdermal delivery of proteins. Pharm. Res. 24, 1357-1359
16. Patel, Y.R. (2006) Altea Therapeutics Transdermal PassPortTM System: Freedom from Insulin Injections for Superior Diabetes Management. ONdrugDelivery
17. Badkar, A.V. et al. (2007) Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm. Res. 24, 1389-1395
18. Levin, G. et al. (2005) Transdermal delivery of human growth hormone through RF-microchannels. Pharm. Res. 22, 550-555
19. Arora, A. et al. (2008) Micro-scale devices for transdermal drug delivery. Int. J. Pharm. 364, 227-236
20. Schuetz, Y.B. et al. (2005) Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 2, 533-548
21. Lee, W.R. et al. (2008) Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J. Control. Rel. 128, 200-208
22. Guy, R.H. et al. (2000) Iontophoresis: electrorepulsion and electroosmosis. J. Control. Rel. 64, 129-132
23. Green, P.G. (1996) Iontophoretic delivery of peptide drugs. J. Control. Rel. 41, 33-48
24. Kanikkannan, N. et al. (1999) Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J. Control. Rel. 59, 99-105
25. Pillai, O. et al. (2003) Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int. J. Pharm. 254, 271-280
26. Pillai, O. and Panchagnula, R. (2003) Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. J. Control. Rel. 89, 127-140
27. Nair, V.B. and Panchagnula, R. (2003) Effects of iontophoresis and fatty acids on permeation of Arginine Vasopressin through rat skin. Pharmacol. Res. 47, 563-569
28. Chang, S.L. et al. (2000) Transdermal iontophoretic delivery of salmon calcitonin. Int. J. Pharm. 200, 107-113
29. Chaturvedula, A. et al. (2005) In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. Int. J. Pharm. 297, 190-196
30. Abla, N. et al. (2005) Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. J. Control. Rel. 108, 319-330
31. Banga, A.K. et al. (1995) Transdermal iontophoretic delivery and degradation of vasopressin across human cadaver skin. Int. J. Pharm. 116, 211-216
32. Katikaneni, S. et al. (2009) Molecular charge mediated transport of a 13 kD protein across microporated skin. Int. J. Pharm. 378, 93-100
33. Pillai, O. et al. (2004) Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. Int. J. Pharm. 269, 109-120
34. Benson, H.A. and Namjoshi, S. (2008) Proteins and peptides: strategies for delivery to and across the skin. J. Pharm. Sci. 97, 3591-3610
35. Banga, A.K. and Prausnitz, M.R. (1998) Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Trends Biotechnol. 16, 408-412
36. Denet, A.R. et al. (2004) Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv. Rev. 56, 659-674
37. Lombry, C. et al. (2000) Transdermal delivery of macromolecules using skin electroporation. Pharm. Res. 17, 32-37
38. Riviere, J.E. et al. (1995) Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin toxicology. J. Control. Rel. 36, 229-233
39. Sen, A. et al. (2002) Transdermal insulin delivery using lipid enhanced electroporation. Biochim. Biophys. Acta 1564, 5-8
40. Chang, S.L. et al. (2000) The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Rel. 66, 127-133
41. Smith, N.B. (2007) Perspectives on transdermal ultrasound mediated drug delivery. Int. J. Nanomed. 2, 585-594
42. Weimann, L.J. and Wu, J. (2002) Transdermal delivery of poly-L-lysine by sonomacroporation. Ultrasound Med. Biol. 28, 1173-1180
43. Mitragotri, S. et al. (1995) Ultrasound-mediated transdermal protein delivery. Science 269, 850-853
44. Mitragotri, S. and Kost, J. (2001) Transdermal delivery of heparin and lowmolecular weight heparin using low-frequency ultrasound. Pharm. Res. 18, 1151-1156
45. Smith, N.B. et al. (2003) Ultrasound-mediated transdermal in vivo transport of insulin with low-profile cymbal arrays. Ultrasound Med. Biol. 29, 1205-1210
46. Boucaud, A. et al. (2002) Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J. Control. Rel. 81, 113-119
47. Park, E.J. et al. (2007) Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm. Res. 24, 1396-1401
48. Foldvari, M. et al. (1999) Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha. Biotechnol. Appl. Biochem. 30 (pt 2), 129-137
49. Magnusson, B.M. and Runn, P. (1999) Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3- methyl-His-Pro amide through human epidermis. Int. J. Pharm. 178, 149-159